Clinical Trials Browser

Withdrawn × Fallopian Tube Neoplasms × olaparib × Clear all

NCT01661868 2012-08-21

Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer

Phase 2 Withdrawn

Fallopian Tube Neoplasms, Ovarian Neoplasms